MBMesut Bilgin

Mesut Bilgin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mesut Bilgin has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Microbiota Regulates Phosphatidylcholine in the Intestinal Mucus Lipidome of Mice in a Strain‐ and Segment‐Dependent Manner

    by Mia Øgaard Mønsted, Mesut Bilgin, Lukasz Krych, Emma Schack Wiedenbein, Camilla Hartmann Friis Hansen, Martin Haupt‐Jorgensen

    Background: Type 1 diabetes (T1D) is associated with intestinal barrier dysfunction, which depends on an intact mucus layer. Phosphatidylcholine (PC) is a major lipid of intestinal mucus that likely exerts an important barrier function due to its hydrophobic and anti‐inflammatory properties. Recently, we showed that PC is reduced in jejunal and colonic mucus in pre‐diabetic non‐obese diabetic (NOD) mice compared to C57BL/6 (B6) mice. As such, PC may play a protective role in T1D. Some bacteria produce PC. However, it is unknown whether T1D‐associated dysbiosis (i.e., altered microbial composition) is behind the reduced PC content in the intestine. Methods: Here, we examined the impact of gut microbiota on jejunal and colonic mucus PC composition. This was done by treating 4 weeks old pre‐diabetic NOD and B6 mice with a broad‐spectrum antibiotic cocktail and by breeding germ‐free BALB/c mice, which were then compared with untreated barrier‐housed NOD, B6 and BALB/c mice. The intestinal mucus lipid profile was analysed by quantitative shotgun lipidomics, while the relative composition of the faecal microbiota was assessed by 16S rRNA gene amplicon sequencing and verified by absolute quantifications using qPCR. Results: Comparing jejunum and colon from the mice revealed that the overall intestinal mucus lipidome was segment‐ but not strain‐specific. Antibiotic treatment reduced colonic PC levels in the NOD and B6 mice, whereas germ‐free conditions did not in the BALB/c mice, which, independent of the presence of microbiota, had the lowest levels of colon PC. The faecal microbiome composition also differed between the three strains of untreated barrier‐housed mice, including reduced abundance of phyla with PC‐containing bacteria in the BALB/c mice. Conclusions: Results suggest that gut microbiota perturbation is an important determinant of intestinal mucus PC content, although the effect seems to depend on the host‐specific baseline microbiota composition.

  • Open Access

    Systems-Level Multi-Omics Analysis Resolves the Mechanism of Action of a Novel Multifunctional Nanosystem Against Triple-Negative Breast Cancer

    by María Pilar Buendia-Nacarino, Dominik Bulfon, Nikola Tom, Mikkel Rohde, Mesut Bilgin, Marja Jäättelä, María Luz Mena, Roberto Alvarez-Fernandez Garcia, Jose L. Luque-Garcia

    Background/Objectives: Triple-negative breast cancer remains a major therapeutic challenge due to its aggressive behavior and limited treatment options. Methods: In this study, an integrated multi-omics strategy combining SILAC-based quantitative proteomics, shotgun lipidomics, and targeted metabolomics was applied to characterize the biomolecular response of MDA-MB-231 cells following exposure to the Ag@MSN-Tf-SeNPs nanosystem. Results and Conclusions: The complementary analytical platforms provided a comprehensive and system-level view of the cytotoxic effects induced by the nanosystem, highlighting its potential as an antitumoral nanotherapeutic approach. Exposure resulted in reduced cell growth and metastatic potential, associated with DNA damage-induced cell-cycle arrest, disruption of protein biosynthesis, and impaired protein quality control linked to Ca2+ homeostasis imbalance. In addition, significant alterations in lipid metabolism were observed, including disruption of cholesterol biosynthesis. These changes, together with disturbances in glycolysis and the tricarboxylic acid cycle, and alterations in NAD+/NADH balance, indicate the induction of oxidative stress driven by reactive oxygen species accumulation. Furthermore, the integration of multi-omics data revealed the activation of compensatory mechanisms aimed at restoring cellular homeostasis, including metabolic rewiring and stress-response pathways, although these responses were insufficient to counteract nanosystem-induced cytotoxicity.


  • Tracer-assisted shotgun lipidomics (TASL): A quantitative workflow integrating stable-isotope tracing with global lipidome profiling

    by Hashmatullah Nasimi, Lya K.K. Holland, Knut K.B. Clemmensen, Jan Stenvang, Marja Jäättelä, Kenji Maeda, Mesut Bilgin


  • Open Access

    Lack of renoprotective effects by long-term PCSK9 and SGLT2 inhibition using alirocumab and empagliflozin in obese ZSF1 rats

    by Sandra Hummelgaard, Henning Hvid, Henrik Birn, Simon Glerup, Nikola Tom, Mesut Bilgin, Jeppe Egedal Kirchhoff, Kathrin Weyer

    New treatments to slow kidney disease progression and reduce cardiovascular disease risk are needed for chronic kidney disease (CKD). We investigated the cholesterol-lowering PCSK9 inhibitor alirocumab as a new treatment for proteinuric CKD and the effect of SGLT2 inhibition using empagliflozin in obese ZSF1 rats. Regarding renoprotection, our findings were contradictory with previous preclinical studies and clinical data, suggesting that different pathophysiological mechanisms may apply to this rat model.


  • Open Access

    Shared and Distinct Lipid Profiles in amygdala from Sporadic and GBA-associated Parkinson’s Diseases

    by Sonia Sanz Muñoz, Frederik Ravnkilde Marlet, Jesper E. Dreier, Mesut Bilgin, Katharina Schott, Krista B. S. Neergaard, Erwan Bezard, Benjamin Dehay, Zane Jaunmuktane, Kenji Maeda, et al.

    Parkinson’s Disease (PD) is a neurodegenerative disorder characterised by the deposition of protein-lipid inclusions, containing alpha-synuclein, neuronal cell loss and disruptions in lipid metabolism such as those associated with GBA mutations. GBA mutations are together an important genetic risk factor for PD and are associated with a decrease in glucocerebrosidase, a lysosomal glycoprotein encoded by GBA , increase in alpha-synuclein and changes in sphingolipids levels and composition. However, the extent of lipid metabolism disruptions associated to PD and their contributions to disease progression remain unclear. In this study, we used a combination of biochemical and lipidomic analyses of amygdala from healthy controls (HC) and people with sporadic (sPD) or GBA-associated PD (PD-GBA) to investigate the correlation between alpha-synuclein, glucocerebrosidase and lipids. We found extensive metabolic remodelling of brain lipids, including increased free cholesterol, diacylglycerides, sphingolipids and specific glycerophospholipids in amygdala from people with sPD and disease duration above 30 years (sPD >30y ) and from people with PD carriers of a GBA risk mutation (PD-GBA risk ) relative to HC. The levels of free cholesterol, diacylglycerides, sphingolipids and specific glycerophospholipids all correlated positively with pathological αS and negatively with GCase activity. In contrast, the levels of phosphatidylethanolamine and cardiolipin only correlated positively with GCase activity. Moreover, we observed changes in the distribution of species for sphingolipids and glycerophospholipids in opposite directions for two categories of PD cases. We found a shift from short to long sphingomyelin and ceramide and from long to short phosphatidylserine and phosphatidylethanolamine in sPD >30y and PD-GBA risk cases and the opposite in sPD and PD-GBA severe cases. The relative proportion of lipid species affected in these samples all correlated with glucocerebrosidase activity and pathological alpha-synuclein levels. Together, these findings highlight the correlation between glucocerebrosidase, pathological alpha-synuclein and lipid levels in PD. Moreover, the identified opposite changes in lipid distribution for two categories of people with sPD and PD-GBA underscore the importance of patient stratification in clinical trials aiming at reverting PD-related lipid changes.


  • Open Access

    Dietary intake of a MFGM/EV-rich concentrate promotes accretion of very long odd-chain sphingolipids and increases lipid metabolic turnover at the whole-body level

    by Richard R. Sprenger, Mesut Bilgin, Marie S. Ostenfeld, Ann Bjørnshave, Jan T. Rasmussen, Christer S. Ejsing


  • Open Access

    Hibernation and plasma lipids in free-ranging brown bears–implications for diabetes

    by Hasim Tekin, Ole Frøbert, Anne Randi Græsli, Jonas Kindberg, Mesut Bilgin, Karsten Buschard

    Brown bears (Ursus arctos) prepare for winter by overeating and increasing adipose stores, before hibernating for up to six months without eating, drinking, and with minimal movement. In spring, the bears exit the den without any damage to organs or physiology. Recent clinical research has shown that specific lipids and lipid profiles are of special interest for diseases such as diabetes type 1 and 2. Furthermore, rodent experiments show that lipids such as sulfatide protects rodents against diabetes. As free-ranging bears experience fat accumulation and month-long physical inactivity without developing diabetes, they could possibly be affected by similar protective measures. In this study, we investigated whether lipid profiles of brown bears are related to protection against hibernation-induced damage. We sampled plasma from 10 free-ranging Scandinavian brown bears during winter hibernation and repeated sampling during active state in the summer period. With quantitative shotgun lipidomics and liquid chromatography-mass spectrometry, we profiled 314 lipid species from 26 lipid classes. A principal component analysis revealed that active and hibernation samples could be distinguished from each other based on their lipid profiles. Six lipid classes were significantly altered when comparing plasma from active state and hibernation: Hexosylceramide, phosphatidylglycerol, and lysophosphatidylglycerol were higher during hibernation, while phosphatidylcholine ether, phosphatidylethanolamine ether, and phosphatidylinositol were lower. Additionally, sulfatide species with shorter chain lengths were lower, while longer chain length sulfatides were higher during hibernation. Lipids that are altered in bears are described by others as relevant for and associated with diabetes, which strengthens their position as potential effectors during hibernation. From this analysis, a range of lipids are suggested as potential protectors of bear physiology, and of potential importance in diabetes.


  • Open Access

    Activation of invasion by oncogenic reprogramming of cholesterol metabolism via increased NPC1 expression and macropinocytosis

    by Aikaterini Skorda, Anna Røssberg Lauridsen, Chengnan Wu, Jinrong Huang, Monika Mrackova, Nuggi Ingholt Winther, Vanessa Jank, Zsofia Sztupinszki, Robert Strauss, Mesut Bilgin, et al.

    Cancer cells are dependent on cholesterol, and they possess strictly controlled cholesterol homeostasis mechanisms. These allow them to smoothly switch between cholesterol synthesis and uptake to fulfill their needs and to adapt environmental changes. Here we describe a mechanism of how cancer cells employ oncogenic growth factor signaling to promote uptake and utilization of extracellular cholesterol via Myeloid Zinc Finger 1 (MZF1)-mediated Niemann Pick C1 (NPC1) expression and upregulated macropinocytosis. Expression of p95ErbB2, highly oncogenic, standard-treatment resistant form of ErbB2 mobilizes lysosomes and activates EGFR, invasion and macropinocytosis. This is connected to a metabolic shift from cholesterol synthesis to uptake due to macropinocytosis-enabled flow of extracellular cholesterol. NPC1 increase facilitates extracellular cholesterol uptake and is necessary for the invasion of ErbB2 expressing breast cancer spheroids and ovarian cancer organoids, indicating a regulatory role for NPC1 in the process. The ability to obtain cholesterol as a byproduct of increased macropinocytosis allows cancer cells to direct the resources needed for the energy-consuming cholesterol synthesis towards other activities such as invasion. These results demonstrate that macropinocytosis is not only an alternative energy source for cancer cells but also an efficient way to provide building material, such as cholesterol, for its macromolecules and membranes.


  • Open Access

    Identification of non-conventional small molecule degraders and stabilizers of squalene synthase

    by Joseph Georg Franz Hoock, Cecilia Rossetti, Mesut Bilgin, Laura Depta, Kasper Enemark-Rasmussen, John C. Christianson, Luca Laraia

    Graphical Squalene synthase (SQS) is an essential enzyme in the mevalonate pathway whose abundance and activity control cholesterol biosynthesis and homeostasis. Although catalytic inhibitors of SQS have been developed to attenuate cholesterol, none so far have been approved for therapeutic use. Herein we sought to develop SQS degraders using targeted protein degradation (TPD) as an approach to lower overall cellular cholesterol content. We found that KY02111, a small molecule ligand of SQS, could selectively cause SQS to degrade in a proteasome-dependent manner. In contrast, compounds based on the same scaffold linked to E3 ligase recruiting ligands led to SQS stabilization. Whole cell proteomic analysis found KY02111 to reduce only the levels of SQS, while lipidomic analysis determined that KY02111 treatment concomitantly reduced cellular cholesteryl ester content. SQS stabilizers were shown to shield SQS from its natural turnover without recruiting their matching E3 ligase. Our work shows that degradation of SQS is possible despite a challenging biological setting and lays the groundwork for future development of either SQS degrading or stabilizing probes.

  • Profiling the Mammalian Lipidome by Quantitative Shotgun Lipidomics

    by Mads Møller Foged, Kenji Maeda, Mesut Bilgin

    The emerging field of lipidomics presents the systems biology approach to identify and quantify the full lipid repertoire of cells, tissues, and organisms. The importance of the lipidome is demonstrated by a number of biological studies on dysregulation of lipid metabolism in human diseases such as cancer, diabetes, and neurodegenerative diseases. Exploring changes and regulations in the huge networks of lipids and their metabolic pathways requires a lipidomics methodology: advanced mass spectrometry that resolves the complexity of the lipidome. Here, we report a comprehensive protocol of quantitative shotgun lipidomics that enables identification and quantification of hundreds of molecular lipid species, covering a wide range of lipid classes, extracted from cultured mammalian cells. Key words Lipidome profiling Lipidomics Shotgun lipidomics Quantification Mammalian cells Mass spectrometry Lipid extraction Systems biology